In all studies to date, few complications are reported typically only mild pain or very brief vertigo during injection and patients can resume normal activity soon after
NCSL Resources on GLP-1 Drugs Prescription Drug Legislation Database Prescription Drug Policy Resource Center The Debate Over Weight-Loss Drugs Diabetes State Mandates and Insulin Copayment Caps The average annual list price of GLP-1s is $12,000 and, according to a Peterson-KFF tracker, most large employer health plans restrict coverage for weight loss
Clarke GN, Clarke FM, Wilson S
Lancet 372(9645):12401250 Drucker DJ, Sherman SI, Gorelick FS, Bergenstal RM, Sherwin RS, Buse JB (2010) Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits
As a result, many patients explore alternative access options such as cash-pay programs and telehealth-based prescribing